Evidence map›Paper›PMID 28239370›Full record

ArticleFrontiers in microbiology2017

Dan Li, Yinjuan Guo, Shanshan Wang, Jingnan Lv, Xiuqin Qi, Zengqiang Chen, Lizhong Han, Xueqing Zhang, Liangxing Wang, Fangyou Yu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Heterogeneous Vancomycin-IntermediateFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Dan LiDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Yinjuan GuoDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Shanshan WangDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Jingnan LvDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Xiuqin QiDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Zengqiang ChenDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Lizhong HanDepartment of Clinical Microbiology, Ruijin Hospital of Shanghai Jiaotong University Shanghai, China.
Xueqing ZhangDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Liangxing WangDepartment of Respiratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
Fangyou YuDepartment of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University Wenzhou, China.
First Affiliated Hospital of Wenzhou Medical University · CNWenzhou Medical University · CNRuijin Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CapB2 is recognized as a tyrosine kinase and is likely a vital factor in extracellular polysaccharide synthesis in

Indexed as

capB2regulationsarAStaphylococcus aureusvirulence factor

Identifiers

PMID28239370
PMCPMC5300969
OpenAlexW2587681459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.